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INTRODUCTION 
Bhagandara is a common disease occurring in 
anorectal region. The word Bhagandara is the 
combination of two words "Bhaga" and "Daran" 
which are derived from root Bhaj and Dri Dhatu 
respectively.
[1]
 The literal meaning of Bhaga is Vagina. 
In Madhava Nidana, Bhaga is used for Vagina, Vasti 
and Guda. In Bhavaprakasha it is used for Yoni and 
Mehana.
[3]
 Bhaga is a word, which means all the 
structures around the Guda including Yoni  and  Basti. 
Address for correspondence: 
 
Dr. Ganapthi Rao. I 
Post Graduate Scholar, Depatrment of Post Graduete Studies in 
Shalya Tantra, N. K.  Jabshetty Ayurvedic Medical College & P.G. 
Centre, Bidar-585403 (Karnataka) 
E-mail: i.ganpathi@gmail.com 
 
 
Submission Date : 03/04/2017 Accepted Date: 28/04/2017 
Access this article online 
Quick Response Code 
Website: www.jaims.in 
 
DOI: 10.21760/jaims.v2i2.7695 
The word Daran means tear of surface associated 
with pain. Finally it can be concluded that 
Bhagandara, is a pathological condition, which causes 
splitting / discontinuity / tear and pain, in the ano-
rectal canal (Guda), vagina (Bhaga) or urinary bladder 
(Vasthi).  The importance of this disease was first 
realized by Acharya Sushruta (800-1000 B.C.), The 
Father of Indian Surgery, who described it elaborately 
in his treatise. 
In western medicine Bhagandara is compared with 
Fistula in ano. The word fistula is derived from a Latin 
word a reed, pipe or flute. It implies a chronic 
granulating track connecting two epithelial-lined 
surfaces. The anal fistula is a single track with an 
external opening in the skin of perianal region and an 
internal opening in the modified skin or mucosa of 
anal canal or rectum.
[12] 
The anal abscess occurs in 26-38% adults in 
developing countries and the incidence of Fistula is 
about 8 -12% per 1,00,000 populations (Dr J Gnanaraj, 
2016). 
A B S T R A C T  
Bhagandara (Fistula in ano) is a common ano-rectal condition prevalent worldwide. Ksharasutra being 
a chief modality in management of Bhagandara in Ayurveda. Exploration of new plants for the 
preparation of Ksharasutra as a better substitute of Apamarga Kshara is need of the hour. Hence 
present research work was planned to evaluate the effect of Palasha Ksharasutra prepared with Arka 
Ksheera and to compare the effect of Palasha Ksharasutra prepared with Arkaksheera and Apamarga 
Ksharasutra in the management of Bhagandara. In this study sample size was 30, patients were 
selected by simple random sampling, 15 in Trial Group and 15 in Control Group. Trial group treated 
with Palasha Ksharasutra prepared with Arkaksheera and Control group treated with Apamarga 
Ksharasutra in Bhagandara. In both group patients were symptoms free after treating, but when 
compared to the cutting rate Apamarga Ksharasutra has average of 0.8cm and Palasha Ksharasutra 
prepared in Arkaksheera with an average of 0.68cm. Thus, Palasha Ksharasutra had equipotent effect 
as Apamarga Ksharasutra. 
Key words: Fistula-in-ano, Bhagandara, Palasha Ksharasutra, Apamarga Ksharasutra. 
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Acharya Sushruta in the 17
th
 chapter of Chikistastana 
mentioned the application of Ksharasutra in Nadi 
Vrana
[4] 
and preparation of Kshara mentioned in 11
th
 
chapter Sutrasthana.
[2]
 The Kshara Sutra therapy was 
practiced and used since long with great success and 
without recurrences. The Apamarga Ksharasutra is 
prepared by repeated coatings of Snuhi Ksheera, 
Apamarga Kshara and Haridra.
[5]
 Still some of the 
problems are facing during the preparation and also in 
the course of Ksharasutra therapy, like collection and 
preservation of Snuhi Ksheera, burning pain during 
primary and successive changes, Local irritant skin 
reactions during course of therapy etc. In spite of the 
good rates of cutting, severe pain and burning 
sensation caused during the treatment with held 
many patients from accepting this treatment. To 
overcome these disadvantages there is a need of most 
important preparation to make the treatment widely 
popular and acceptable.  
Overcoming the causation of pain and burning 
sensation was a very important necessity because of 
which surgeons of Ayurveda came out with newer 
ideas. Thus it gave to many Ksharasutras were tried 
out. Though each of the thread had good cutting rates 
and other preparation advantages they also had some 
disadvantages. Keeping in view the same idea Palasha 
Ksharasutra
[2]
 prepared in Arka Ksheera was tried in 
the present study. 
OBJECTIVES 
To evaluate the effect of Palasha Kshara Sutra 
prepared in Arkaksheera and to compare the effect of 
Palasha KsharaSutra prepared with Arkaksheera and 
Apamarga Kshara Sutra in the management of 
Bhagandara. 
MATERIALS AND METHODS 
Present study was an open clinical study in which 30 
patients were selected on the basis of simple random 
sampling (SRS) procedure and divided in 2 equal 
groups, strictly confined to the treatment of low anal 
fistula (sub-cutaneous). It was performed on the 
patients who attended the outpatient and inpatient 
department of Shalya Tantra, Sri Siddharudha 
Chariatable Hospital, a teaching hospital of N.K.J. 
Ayurvedic Medical College and P.G Centre, Bidar. 
Group I - 15 Patients were treated with Palasha 
Ksharasutra prepared in Arka Ksheera. 
Group II - 15 Patients were treated with Apamarga 
Ksharasutra prepared in Snuhi Ksheera. 
Inclusion Criteria 
Criteria for the selection of patient were based on the 
following. 
1. Irrespective of Age, Sex, Religion, Occupation, 
Economic status, Education status. 
2. Patients with low anal fistula (Bhagandara). 
3. Patients within the age of 16-65yrs. 
Exclusion Criteria 
Exclusion criteria were based on the following 
1. Patients suffering from systemic diseases will be 
excluded 
2. Patients with high rectal fistula will be excluded. 
3. Patients suffering from CA of rectum, HbsAg and 
HIV will also be excluded 
4. Patients suffering from ulcerative colitis, 
crohn’sdisease, Osteomyelitis of Pubic Bone will 
be excluded from the study. 
Poorva Karma 
The following instructions were advised before 
application of Palasha Ksharasutra, 
 Administration of mild laxatives for regularization 
of bowels. 
 Written Consent 
 Patients were asked to maintain proper local part 
preparation and general hygiene. 
 To control the local infection, inflammation, 
indurations, itching etc., with proper medicines. 
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 Administration of inj. Tetanus toxoid. 
Pradhana Karma 
Group 1: Application of Palasha Ksharasutra.
 
For the application of Palasha Ksharasutra the 
patients were asked to lie in lithotomy position and 
perianal region was cleaned with antiseptic lotions 
and draped. The patients were assured and gloved 
finger was gently introduced into the rectum. Then a 
suitable selected probe was passed through the 
external opening of fistula. The tip of the probe was 
forwarded along the path of least resistance being 
guided by the finger in rectum to reach into the lumen 
of anal canal through the internal opening and its tip 
was finally directed to come out of anal orifice. 
Palasha Ksharasutra was taken and threaded into the 
eye of probe, thereafter the probe was pulled out 
through the anal orifice to leave the thread behind in 
the fistulous track. The two ends of the thread were 
then tied together with a moderate tightness outside 
the anal canal.
[6]
 
Group 2: Application of the Apamarga Ksharasutra. 
For the application of Apamarga Ksharasutra, the 
patient were asked to lie in lithotomic position and 
perianal region was cleaned with antiseptic lotions 
and draped. Thus, the patient was assured and gloved 
finger was gently introduced into the rectum. Then, a 
suitable selected probe was passed through the 
external opening of fistula. The tip of the probe was 
forwarded along the path of least resistance being 
guided by the finger in rectum to reach into the lumen 
of anal canal through the internal opening and its tip 
was finally directed to come out of anal orifice. 
Apamarga Ksharasutra was taken and threaded into 
the eye of probe. Thereafter the probe was pulled out 
through the anal orifice to leave the thread behind in 
the fistulous track. The two ends of the thread were 
then tied together with a moderate tightness outside 
the anal canal.
[6]
 
Paschat Karma  
After Application of Palasha Ksharasutra; 
1. Patient were asked to have sitz bath daily twice or 
thrice from 2
nd
 day onwards with Triphala 
Kashaya. 
2. Triphala Guggulu one tablet given twice a day 
after food. 
3. To attend hospital for regular dressing and weekly 
change of thread. 
4. To take leafy vegetables, fruits, buttermilk etc., 
diet which would be nutritious easily digestible to 
develop the general condition of the patient and 
to avoid constipation. 
5. To avoid non vegetarian foods and spicy foods. 
6. To avoid prolong sitting and standing, riding on 
hard seats etc. 
7. To avoid straining during defecation.  
8. Ambulation of the patients was made a routine to 
encourage all the patients to remain as active as 
possible and to lead a perfectly normal life both 
physically as well as mentally. 
Changing of the thread - In both the groups, thread 
was changed once in a week i.e. on 7
th
 day, 14
th
 day, 
21
st 
day and 28
th 
day. Thread was changed by road - 
rail method. 
Assessment Criteria 
The clinical examinations of the patient were 
conducted before and after treatment and 
accordingly the effectiveness were evaluated as per 
the assessment criteria fixed. The subjective and 
objective parameters for assessment are as follows. 
Subjective Parameters 
Pain 
Assessed by visual analog scale of pain 
 G0 - 0 - Absence of pain/no pain. 
 G1 - 1 to 3 mark on scale, Mild pain that can easily 
be ignored. 
 G2 - 4 to 6 mark on scale, Moderate pain that 
cannot be ignored, interferes with function, and 
needs treatment from time to time. 
 G3 - 7 to 10 marks on scale, Severe pain, that is 
present most of the time demanding constant 
attention. 
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Swelling 
 G0 - Absent 
 G1 - Slight swelling around the wound margin 
without indurations. 
 G2 - Swelling around wound margin with little area 
of indurations.  
 G3 - Swelling with marked indurations. 
Itching 
 G0 - No itching 
 G1 - Itching sometimes but not interfering with 
activities and can be controlled voluntarily. 
 G2 - Itching interferes with function, involuntary 
and uncontrolled associated with skin patches 
 G3 - Itching that disturbs the sleep and/or demand 
treatment, associated with skin patches. 
Discharge -  was assessed by measuring the discharge 
by a pad of (3× 3) × 1 cm. 
 G0 - No discharge 
 G1 - Mild discharge, single pad is sufficient per 
day. 
 G2 - Moderate discharge, 2 to 3 pads are 
necessary per day. 
 G3 - Profuse discharge more than three pads are 
necessary per day. 
Objective Parameter 
1) Local tenderness - was assessed by palpation of 
anal region. 
 G0 - No tenderness. 
 G1 - Mild tender but can be palpated. 
 G2 - Moderate tender on gentle palpation. 
 G3 - Severe tenderness, patient denies touching. 
2) Indurations 
 G0 - Absent 
 G1  - Slight swelling around the wound margin 
without indurations. 
 G2 - Swelling around the wound margin with little 
area of indurations. 
 G3 - Swelling with marked indurations. 
3) Length of tract (in cms) 
  	
 =
 
  
 
  
  
	
. 

 


  
Assessment of Result 
For the purpose of the assessment of result we have 
used some grade points considering the severity of 
different sign and symptoms as follows. 
Sign Grade Grade Point 
+++ G3 3 
++ G2 2 
+ G1 1 
- G0 0 
Clinical assessment of result 
 Cure - 100% free from cardinal signs and 
symptoms, these are pain, swelling, discharge, 
itching, local tenderness, length of tract etc. 
 Max. Improvement - 75% to 99% improvement of 
the above mentioned cardinal signs and 
symptoms. 
 Moderate Improvement - 50% to 74% 
improvement of the above mentioned cardinal 
signs and symptoms. 
 Mild Improvement - 25% to 49% improvement of 
the above mentioned cardinal signs and 
symptoms. 
 No. Improvement - Less than 25% improvement 
of the above mentioned cardinal signs and 
symptom. 
Study Design 
According to the procedure stated above thirty 
patients with low anal fistula were selected for the 
study by random sampling technique method. 
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Group design 
BT G1 vs 
AT G1 will be 
assessed 
AT G1 vs 
AT G2 
will be 
compared BT G2 vs 
AT G2 
The clinical assessment was done in every 7 days 
interval. The initial findings were taken through 
clinically, pathologically and statements were 
compared with the result of progressive 7
th
 day, 14
th
 
day and so on. Grading and grouping according to the 
assessment criteria and measurement scale 
concerned to each item categorically differentiated 
the findings among the patients in the clinical study. 
And finally the assessment as a whole was presented 
in percent value. In order to present the study in a 
scientific manner, the statistical assessment of the 
result were assessed by the result mean ± S.D of each 
sign and symptom before treatment has been 
compared with mean ± S.D value of after treatment. 
Paired t - test was used for the purpose of the test of 
significance. The effectiveness of Palasha Ksharasutra 
and Apamarga Ksharasutra were assessed through p - 
value. 
OBSERVATION AND RESULTS 
The present study was carried out on total 30 patients 
in two groups as prospective study by simple 
randomized method of selection. The patients were 
tested in this clinical trial for Palasha Ksharasutra and 
Apamarga Ksharasutra. The following observations 
were made during the course of the present clinical 
research. 
Incidence according to Age and Sex 
It has been observed from the study that, out of 30 
patients, maximum No. of patients i.e. 09 (30.00%) 
were in between the age group 41 to 50 years, 
minimum patients reported in between the age group 
61 to 70 years i.e. 03(10.00%) collectively there were 
23 males and 07 female patients. 
Incidence according to Religion 
It was evidenced from the study that, out of 30 
patients, maximum No. of patients 14 (46.67%) were 
Muslim, 7 (23.33%) Hindu patients reported, 6 (20%) 
Christian patients were found and 3 (10%) Sikh 
patients were reported. 
Incidence according to Marital Status 
This study shows that incidence of Bhagandara was 
more in married patients with a percentage of 73.33% 
(22).  
Incidence according to Occupation 
This study shows distribution of patients according to 
occupation and its percentage. Incidence was more in 
labour class i.e. 15 patients 50.00%, service 05 
(16.67%) patients, house wife 04 (13.33%) patients, 
student and business 03 (10%) patients were found. 
Incidence according to Education 
Incidence of education status revealed that 19 
patients were uneducated i.e. (63.33%) and 11 
patients were educated i.e. (36.67%). 
Incidence according to socioeconomic status 
Analysis of socio-economic status of 30 cases of 
Fistula-in-ano revealed that majority of patients i.e. 
15(50%) belongs to poor class, 12 (40%) patients 
belongs to middle class and 03 (10%) patients from 
rich class were reported. 
Incidence according to Dietary habits 
The distribution of patients reveals that the maximum 
numbers of cases (72.6%) were habituated to take 
Non-vegetarian diet. 
Table 1: Average unit cutting time (U.C.T.) of Group - 
1 
No. of 
patients 
Initial 
length 
of 
Track 
(cms) 
BT. 
7
th
 
day 
14
th
 
day 
21
st
 
day 
28
th
 
day 
Average 
U.C.T. 
1. 4 4 3.5 2.4 1.2 0.7 
2. 3 3 2.4 1.1 0.4 0.6 
3. 4 3.8 2.7 1.9 1 0.7 
4. 3.4 2.8 1.9 1.5 0.5 0.7 
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5. 2 2 1.4 0.6 0 0.5 
6. 3 3 2.6 2 1 0.5 
7. 4 4 3.2 2.1 0.9 0.7 
8. 3 2.6 2 1 0.2 0.7 
9. 2.5 2 1.6 1.2 0.2 0.5 
10. 4 4 3.2 2 0.6 0.8 
11. 4.5 4 3.1 2 0.3 1 
12. 4 4 3.4 2 1.3 0.6 
13. 3 2.9 2 0.7 0.2 0.7 
14. 3 3 2.3 1.1 0.3 0.7 
15. 4 4 3.2 2 0.5 0.8 
Average U.C.T. = 0.68cm 
Table 2: Average unit cutting time (U.C.T.) of Group - 
2 
No. of 
patients 
Initial 
length 
of 
Track 
(cms) 
BT. 
7
th
 
day 
14
th
 
day 
21
st
 
day 
28
th
 
day 
Average 
U.C.T. 
1. 6 5.8 4.9 3.7 2.2 0.9 
2. 4 4 3.2 2 0.5 0.8 
3. 4.5 4 2.8 1.4 0.5 1 
4. 3.5 2.6 1.3 0.5 0 0.8 
5. 5 4.5 3.9 2.4 1.2 0.9 
6. 3 3 2.4 1.2 0 0.7 
7. 4 3.8 2.6 1.4 0.5 0.8 
8. 2.5 2.5 2 1.2 0 0.6 
9. 4.5 4.5 3.6 2.5 1.5 0.7 
10. 5 5 4 3.2 1.5 0.8 
11. 3.5 3 2.5 1.5 0.7 0.7 
12. 5.5 5.5 4.5 3.8 2.2 0.8 
13. 3 3 2.3 1 0 0.7 
14. 4 3.8 3 1.6 0.5 0.8 
15. 5 4.5 3.6 2.2 1 1 
Average U.C.T.   =  0.8 cm 
RESULT 
In the present clinical study the result of all the cases 
were noted on the basis of following points. 
Table 3: Showing the effect of Trial group 
Sign and 
Sympto
ms 
BT  
Mean 
± S.E. 
Asses
smen
t 
Mea
n ± 
S.E. 
t  p  Effecti
veness 
% 
Re
ma
rk 
Pain on 
VAS 
2.06±0.
18 
1 2.06±
0.18 
0.
56 
>0.
05 
2.85 NS 
2 1.86±
0.13 
3.
68 
<0.
00
1 
27.77 HS 
3 1.53±
0.16 
15
.5
8 
<0.
00
1 
27.77 HS 
4 0.86±
0.13 
18
.6
6 
<0.
00
1 
48.57 HS 
Swelling 2.21±0.
18 
1 2.21±
0.18 
1.
46 
>0.
05 
6.66 NS 
2 2.21±
0.18 
1.
46 
>0.
05 
6.66 NS 
3 1.21±
0.10 
6.
51 
<0.
00
1 
45.16 HS 
4 0.42±
0.13 
14
.5
0 
<0.
00
1 
80.64 HS 
Itching 2.06±0.
18 
1 2.06±
0.18 
0.
56 
>0.
05 
3.12 NS 
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2 2.06±
0.18 
0.
56 
>0.
05 
3.12 NS 
3 1±0.1
3 
9.
02 
<0.
00
1 
51.61 HS 
4 0.4±0
.13 
10
.4
5 
<0.
00
1 
80.64 HS 
Discharg
e 
2.33±0.
18 
1 2.33±
0.18 
2.
25 
<0.
05 
10.52 S 
2 1.73±
0.15 
4.
58 
<0.
00
1 
25.714 HS 
3 1.2±0
.10 
6.
85 
<0.
00
1 
48.57 HS 
4 0.46±
0.13 
20
.5
4 
<0.
00
1 
80 HS 
Local 
Tenderne
ss 
2.4±0.1
3 
1 2.4±0
.13 
1 >0.
05 
2.85 NS 
2 1.73±
0.15 
5.
29 
<0.
00
1 
27.77 HS 
3 1.2±0
.10 
11
.2
2 
<0.
00
1 
50 HS 
4 0.66±
0.12 
14
.6
6 
<0.
00
1 
72.22 HS 
Length of 
Track 
3.46±0.
17 
1 3.46±
0.17 
10
.6
6 
<0.
00
1 
28.03 HS 
2 2.50±
0.17 
10
.2
6 
<0.
00
1 
25.8 HS 
3 1.57±
0.14 
17
.8
0 
<0.
00
1 
54.52 HS 
4 0.57±
0.10 
19
.5
5 
<0.
00
1 
83.42 HS 
Df = 14 
The above statistical analysis shows that in case of 
Pain- The mean ± S.E. before treatment was 
2.06±0.18 and was same 2.06±0.18 after 7 days, was 
reduced to 1.86±0.13 after 14 days, 1.53±0.16 after 
21 days and 0.86±0.13 after 28 days. The test of 
significance shows that Palasha is highly significant to 
reduce pain with the P-value < 0.001 in AT1, AT2, AT3 
and AT4 respectively. 
Swelling- The mean ± S.E. before treatment was 
2.21±0.18, was same 2.21±0.18 after 7 days, was  
reduced to 2.21±0.18 after 14 days, 1.21±0.10 after 
21 days and 0.42±0.13 after 28 days. The test of 
significance shows that Palasha is highly Significant to 
reduce swelling with the P-value < 0.001 in AT1, AT2, 
AT3 and AT4 respectively. 
Itching- The mean ± S.E. before treatment was 
2.06±0.18, was same 2.06±0.18 after 7 days, 
2.06±0.18 after 14 days, was reduced to 1±0.13 after 
21 days and 0.4±0.13 after 28 days. The test of 
significance shows that Palasha is highly significant to 
reduce itching with the P-value < 0.001in AT1, AT2, 
AT3 and AT4 respectively. 
Discharge- The mean ± S.E. before treatment was 
2.33±0.18, was same 2.33±0.18 after 7 days, was 
reduced to 1.73±0.15 after 14 days, and 1.2±0.10 
after 21 days and 0.46±0.13 after 28 days. The test of 
significance shows that Palasha is highly significant to 
reduce discharge with the P-value < 0.001 in AT1, AT2, 
AT3 and AT4 respectively. 
Local of Tenderness- The mean ± S.E. before 
treatment was, 2.4±0.13 and was same 2.4±0.13 after 
7 days, was reduced to1.73±0.15 after 14 days and 
1.2±0.10 after 21 days, 0.66±0.12 after 28 days. The 
test of significance shows that Palasha is highly 
significant to reduce local tenderness with the P-value 
< 0.001 in AT1, AT2, AT3 and AT4 respectively. 
Length of track- The mean ± S.E. before treatment 
was 3.46±0.17 and was same 3.46±0.17 after 7 days, 
were reduced to 2.50±0.17 after 14 days, 1.57±0.14 
after 21 days and 0.57±0.10 after 28 days. The test of 
significance shows that Palasha is highly Significant to 
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reduce length of track with the P-value < 0.001 in AT1, 
AT2, AT3 and AT4 respectively. 
Table 4: Showing the effect of Control Group 
Sign and 
Sympto
ms 
BT  
Mean 
± S.E. 
Asses
smen
t 
Mea
n ± 
S.E. 
t p Effecti
veness 
% 
Re
ma
rk 
Pain on 
VAS 
1.53±0.
16 
1 1.53±
0.16 
4.
67 
>0.
05 
2.85 NS 
2 1.73±
0.15 
2.
25 
>0.
00
1 
10.52 S 
3 1.26±
0.15 
7.
29 
<0.
00
1 
36.84 HS 
4 0.73±
0.11 
8.
76 
<0.
00
1 
52.94 HS 
Swelling 2.13±0.
16 
1 2.13±
0.16 
1.
46 
>0.
05 
6.06 NS 
2 2.06±
0.18 
0.
56 
>0.
05 
3.12 NS 
3 1.13±
0.135 
7.
24 
<0.
00
1 
46.8 HS 
4 0.2±0
.10 
16
.3
5 
<0.
00
1 
90.625 HS 
Itching 2.06±0.
18 
1 2.06±
0.18 
1.
87 
>0.
05 
9.67 NS 
2 1.86±
0.13 
1.
87 
>0.
05 
9.67 NS 
3 0.86±
0.13 
8.
29 
<0.
00
5 
58.06 S 
4 0.2±0
.10 
9.
72 
<0.
00
1 
90.32 HS 
Discharg
e 
2.13±0.
13 
1 2.13±
0.13 
0.
56 
>0.
05 
3.03 NS 
2 1.6±0
.13 
4 >0.
00
1 
25 S 
3 1±0 8.
5 
<0.
00
53.12 HS 
1 
4 0.2±0
.10 
12
.6
1 
<0.
00
1 
90.62 HS 
Local 
Tenderne
ss 
2.4±0.1
3 
1 2.4±0
.13 
1 >0.
05 
2.85 NS 
2 1.6±0
.13 
5.
24 
<0.
00
1 
35.13 HS 
3 1.33±
0.09 
10
.5
8 
<0.
00
1 
54.05 HS 
4 0.33±
0.12 
23
.4
8 
<0.
00
1 
86.48 HS 
Length of 
Track 
4.2±0.2
5 
1 4.2±0
.25 
2.
61 
<0.
05 
21.18 S 
2 3.10±
0.25 
9.
66 
<0.
00
1 
26.03 HS 
3 1.97±
0.25 
1.
67 
<0.
00
1 
53.01 HS 
4 0.82±
0.19 
29
.5
6 
<0.
00
1 
80.47 HS 
Df = 14 
The above statistical analysis shows that in case of 
Pain - The mean ± S.E.1.53±0.16 before treatment 
was same 1.53±0.16 after 7 days, was reduced to 
1.73±0.15 after 14 days, 1.26±0.15 and after 21 days. 
0.73±0.11 after 28 days. The test of significance shows 
that Apamarga is highly Significant to reduce pain 
with the P-value <0.001 in AT1, AT2, AT3 and AT4 
respectively. 
Swelling - The mean ± S.E. before treatment was 
2.13±0.16 and was same 2.13±0.16 after 7 days, was  
reduced to 2.06±0.18 after 14 days, 1.13±0.135 after 
21 days and 0.2±0.10 after 28 days. The test of 
significance shows that Apamarga is highly significant 
to reduce swelling with the P-value <0.001 in AT1, 
AT2, AT3 and AT4 respectively. 
Itching - The mean ± S.E. before treatment was 
2.06±0.18 and was same 2.06±0.18 after 7 days, was  
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reduced to 1.86±0.13 after 14 days, and 0.86±0.13 
after 21 days and 0.2±0.10 after 28 days. The test of 
significance shows that Apamarga is highly significant 
to reduce itching with the P-value < 0.001 in AT1, AT2, 
AT3 and AT4 respectively. 
Discharge - The mean ± S.E. before treatment was 
2.13±0.13, was same 2.13±0.13 after 7 days, was 
reduced 1.6±0.13 after 14 days, 1±0 after 21 days and 
0.2±.10 after 28 days. The test of significance shows 
that Apamarga is highly significant to reduce 
discharge with the P-value < 0.001 in AT1, AT2, AT3 
and AT4 respectively. 
Local of Tenderness - The mean ± S.E. before 
treatment was 2.4±0.13, was same 2.4±0.13 after 7 
days, was reduced to1.6±0.13 after 14 days, 1.33±0.09 
after 21 days and 0.33±0.12 after 28 days. The test of 
significance shows that Apamarga is highly significant 
to reduce local tenderness with the P-value <0.001 in 
AT1, AT2, AT3 and AT4 respectively. 
Length of track - The mean ± S.E. before treatment 
was 4.2±0.25 and was same 4.2±0.25 after 7 days, was 
reduced 3.10±0.25 after 14 days, and 1.97±0.25 after 
21 days, 0.82±0.19 after 28 days. The test of 
significance shows that Apamarga is highly significant 
to reduce Length of track with the P-value <0.001 in 
AT1, AT2, AT3 and AT4 respectively. 
Overall clinical assessment of therapy 
In Group I, 12 patients (80%) completely cured. In 
group II, 14 patients (93.33%) got completely cured. 
Finally overall assessment of the therapy was 
analyzed clinically. 
Where at the 1
st
 follow up on 7
th
 day in group - I 
Moderate improvement in 2 patients i.e. (13.33%). 
Mild improve in 5 patients i.e. (33.33%) and not 
improvement was noticed in 8 patients i.e. (53.33%) 
whereas group- II Moderate improvement in 3 
patients i.e. (20%).Mild improve in 4 patients i.e. 
(26.67%) and not improvement was noticed in 8 
patients i.e. (53.33%). 
Where at the 2
nd
 follow up on 14
th
 day in group - I 
Maximum improvement in 2 patients i.e (13.33%). 
Moderate improvement in 3 patients i.e. (20%). Mild 
improve in 4 patients i.e. (26.67%) and not 
improvement was noticed in 6 patients i.e. (40%) 
whereas group - II Maximum improvement in 3 
patient’s i.e. (20%). Moderate improvement in 5 
patients i.e. (33.33%). Mild improve in 3 patients i.e. 
(20%) and not improvement was noticed in 4 patients 
i.e. (26.67%) 
Where at the 3
rd 
follow up on 21
st
 day in group - I, 1 
patients i.e. (6.67%) was Cured and Maximum 
improve in 3 patients i.e. (20%). Moderate 
improvement in 6 patients i.e. (40%). Mild improve in 
3 patients i.e. (20%) and not improvement was 
noticed in 2 patients i.e. (13.33%). Whereas group - II,   
2 patients i.e. (13.33%) were Cured and Maximum 
improve in 5 patients i.e. (33.33%). Moderate 
improvement in 4 patients i.e. (26.67%) Mild improve 
in 3 patients i.e. (20%) and not improvement was 
noticed in 1 patient i.e. (6.67%). 
Whereas the 4th follow up on 28
st
 day in group - I, 12 
patients i.e. (80%) was Cured and Maximum improve 
in 3 patients i.e. (20%). group - II   14 patients i.e. 
(93.33%) was Cured and Maximum improve in 1 
patient i.e. (6.66%). 
Table 5: Average Unit cutting time in days/cm in 
Control and Trial Groups 
Group of 
Patient 
pH 
Mean ± 
S.E. 
t - value 
& P -
value 
Average 
CUT 
cms/day 
Apamarga 
Kshara 
Sutra -
15(C.G) 
9.72 4.2±0.25 
29.56 & 
<0.001 
0.80 
Palasha 
Kshara 
Sutra -
15(T.G) 
7.5 3.46±0.17 
19.55 & 
<0.001 
0.68 
After comparison of all above figures of sign and 
symptoms in Trial and Control groups, we can 
conclude that the treatment used in trial group i.e. 
Palasha Kshara Sutra prepared with Arka Ksheera is 
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having equipotent effect as compared to the 
treatment  control group Apamarga Ksharasutra. 
DISCUSSION 
The assessment of results is mainly based on 
parameters like pain, swelling, itching, discharge, 
induration, tenderness and unit cutting time (UCT). 
Discussion on Pain: In the trial group before 
treatment mean and SE assessed over the pain were 
2.06 after the treatment it was reduced to 0.86 
showing highly significant effect because of Vedana 
Shamaka, Ksharana, Teekshna and Ushnaguna and 
chemical constituents butin, calotropian, glycosides 
are having pain relieving properties of the 
Palashakshara and Arkaksheera definitely debribes 
fistula tract followed with continuous pus drainage 
subsequently reduces pain.
[9]
 
Discussion on Swelling: In the trial group before 
treatment mean and SE assessed over the induration 
was 2.21 after the treatment it was reduced to 0.42 
showing highly significant effect because of Antikatu, 
Tikta, Kashaya Rasa, Laghu, Ruksha, Teekshnaguna, 
Ushnaveerya of the proposed drug reduces the tissue 
response.
[9] 
Discussion on Itching: In the trial group before 
treatment mean and SE assessed over the itching was 
2.06 after the treatment it was reduced to 0.4 
showing highly significant effectbecause of Krimigna, 
Kandugna properties of Palashakshara and 
Arkaksheera possesses the antipruritic action.
[40]
 
Chemical constituents butin, tannin, protimin, 
calotropian are having antifungal property which 
reduces itching.
[11]
 
Discussion on Discharge: In the trial group before 
treatment mean and SE assessed over the discharge 
was 2.33 after the treatment it was reduced to 0.46 
showing highly significant effect, debribment action of 
the Ksharana, Vranaropana properties of 
Palashakshara and Arkaksheera definitely reduces the 
different type of discharges.
[10]
 
Discussion on Induration: In the trial group before 
treatment mean and SE assessed over the induration 
was 2.21 after the treatment it was reduced to 0.42 
showing highly significant effect because of Antikatu, 
Tikta, Kashaya Rasa, Laghu, Ruksha, Teekshnaguna, 
Ushnaveerya of the proposed drug reduces the tissue 
response.
[9]
 
Discussion on Tenderness: In the trial group before 
treatment mean and SE assessed over the local 
tenderness was 2.4 after the treatment it was 
reduced to 0.66 showing highly significant effect 
because Vedanashamaka properties, butin, 
monospermin, tannin and proteolitin chemical 
constituents of the proposed drug increases cutting 
rate of the fistulas tract subsequently reduces the 
surrounding tenderness.
[10]
 
Discussion on Unit Cutting Time: Average U.C.T. is 
0.8cm/day in control group compared to 0.68cm/day 
in trial group. In the trial group before treatment 
mean and SE assessed over the length of track were 
3.46 after the treatment it was reduced to 0.57 
showing highly significant effect. The average UCT was 
0.68cms/day. Because Palashaksharasutra prepared 
with Arkaksheera having the Chedana, Bhedana, 
Ksharana and Ropana properties of proposed drug 
may reduce the length of the tract. Apamarga 
Ksharasutra is alkaline and its pH is 9.72, whereas 
Palasha Ksharasutra is alkaline with pH of 7.5. So the 
pain and burning sensation was comparatively less in 
trial group with U.C.T. almost equal to control group 
0.8cm/day in control group compared to 0.68cm/day 
in trial group. 
In group I, 12 patients (80%) and In group II, 14 
patients (93.33%) got complete cured. Finally overall 
assessment of the therapy was analyzed clinically, 
Where at the 1
st
 follow up on 7
th
 day in group - I; 
Moderate improvement in 2 patients (13.33%), Mild 
improvement in 5 patients (33.33%) and no 
improvement was noticed in 8 patients (53.33%) 
where as in group - II; Moderate improvement in 3 
patients (20%), Mild improvement in 4 patients 
(26.27%) and no improvement was noticed in 8 
patients (53.33%), 
Where at the 2
st
 follow up on 14
th
 day in group - I, 
Maximum improvement in 2 patients (13.33%). 
Moderate improvement in 3 patients (20%). Mild 
improvement in 4 patients (26.66%) and no 
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improvement was noticed in 6 patients (40%) where 
as in group - II Maximum improvement in 3 patients 
(20%). Moderate improvement in 5 patients (33.33%). 
Mild improvement in 3 patients (20%) and no 
improvement was noticed in 4 patients (26.66%). 
Where at the 3
rd
 follow up on 21
st
 day in group - I, 1 
patient (6.66%) was cured and maximum 
improvement in 3 patients (20%). Moderate 
improvement in 6 patients (40%). Mild improvement 
in 3 patients (20%) and no improvement was noticed 
in 2 patients (13.33%). Whereas group - II, 2 patients 
(13.33%) was cured and maximum improvement in 5 
patients (33.33%). Moderate improvement in 4 
patients (26.66%), mild improvement in 3 patients 
(20%) and no improvement was noticed in 1 patient 
(6.66%). 
Whereas the 4
th
 follow up on 28
st
 day in Group - I, 12 
patients (80%) were cured and maximum 
improvement in 3 patients (20%). Group - II, 14 
patients (93.33%) were cured and maximum 
improvement in 1 patient (6.66%). 
After comparison of all above figures of signs and 
symptoms in trial and control groups, we can 
conclude that the treatment used in Bhagandara 
(Fistula-in-ano) Palashaksharasutra prepared with 
Arkaksheera is having equipotent result as compared 
to Apamargaksharasutra. 
CONCLUSION 
Based on the above clinical statistical data it may be 
concluded that the management of Bhagandara by 
Ksharasutra has been proved effective by this study. 
The undesired effects of Ksharasutra management 
could be minimized by using Palasha Ksharasutra 
prepared with Arkaksheera. Palasha Ksharasutra 
prepared in Arkaksheera has been found very 
effective in relieving symptoms i.e. reduces pain, 
swelling, itching, discharge and local tenderness in 
fistula in short duration. Palasha Ksharasutra 
prepared with Arkaksheera is best alternative to 
Apamarga Ksharasutra prepared in Snuhiksheera in 
the management of Bhagandara. 
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